BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 26537119)

  • 1. Metformin and prostate cancer mortality: a meta-analysis.
    Stopsack KH; Ziehr DR; Rider JR; Giovannucci EL
    Cancer Causes Control; 2016 Jan; 27(1):105-13. PubMed ID: 26537119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of metformin on clinical outcomes among men with prostate cancer: a systematic review and meta-analysis.
    Raval AD; Thakker D; Vyas A; Salkini M; Madhavan S; Sambamoorthi U
    Prostate Cancer Prostatic Dis; 2015 Jun; 18(2):110-21. PubMed ID: 25667109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between metformin therapy and incidence, recurrence and mortality of prostate cancer: evidence from a meta-analysis.
    Deng D; Yang Y; Tang X; Skrip L; Qiu J; Wang Y; Zhang F
    Diabetes Metab Res Rev; 2015 Sep; 31(6):595-602. PubMed ID: 25708557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metformin use and all-cause and prostate cancer-specific mortality among men with diabetes.
    Margel D; Urbach DR; Lipscombe LL; Bell CM; Kulkarni G; Austin PC; Fleshner N
    J Clin Oncol; 2013 Sep; 31(25):3069-75. PubMed ID: 23918942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of metformin on cancer risk and treatment outcome of prostate cancer: a meta-analysis of epidemiological observational studies.
    Yu H; Yin L; Jiang X; Sun X; Wu J; Tian H; Gao X; He X
    PLoS One; 2014; 9(12):e116327. PubMed ID: 25545701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metformin therapy associated with survival benefit in lung cancer patients with diabetes.
    Wan G; Yu X; Chen P; Wang X; Pan D; Wang X; Li L; Cai X; Cao F
    Oncotarget; 2016 Jun; 7(23):35437-45. PubMed ID: 27105507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antidiabetic drug use and prostate cancer risk in the Finnish Randomized Study of Screening for Prostate Cancer.
    Haring A; Murtola TJ; Talala K; Taari K; Tammela TL; Auvinen A
    Scand J Urol; 2017 Feb; 51(1):5-12. PubMed ID: 28084175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of diabetes mellitus and metformin use on oncologic outcomes of patients treated with radical cystectomy for urothelial carcinoma.
    Rieken M; Xylinas E; Kluth L; Crivelli JJ; Chrystal J; Faison T; Lotan Y; Karakiewicz PI; Sun M; Fajkovic H; Babjuk M; Bachmann A; Scherr DS; Shariat SF
    Urol Oncol; 2014 Jan; 32(1):49.e7-14. PubMed ID: 24140245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of metformin on mortality following cancer among patients with diabetes.
    Lega IC; Shah PS; Margel D; Beyene J; Rochon PA; Lipscombe LL
    Cancer Epidemiol Biomarkers Prev; 2014 Oct; 23(10):1974-84. PubMed ID: 25030683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of metformin in patients with prostate cancer and the risk of death.
    Bensimon L; Yin H; Suissa S; Pollak MN; Azoulay L
    Cancer Epidemiol Biomarkers Prev; 2014 Oct; 23(10):2111-8. PubMed ID: 25017246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metformin effects on biochemical recurrence and metabolic signaling in the prostate.
    Winters B; Plymate S; Zeliadt SB; Holt S; Zhang X; Hu E; Lin DW; Morrissey C; Wooldridge B; Gore JL; Porter MP; Wright JL
    Prostate; 2015 Nov; 75(15):1694-703. PubMed ID: 26201966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metformin Improves Overall Survival of Colorectal Cancer Patients with Diabetes: A Meta-Analysis.
    Meng F; Song L; Wang W
    J Diabetes Res; 2017; 2017():5063239. PubMed ID: 28271076
    [No Abstract]   [Full Text] [Related]  

  • 13. Metformin use and prostate cancer risk.
    Preston MA; Riis AH; Ehrenstein V; Breau RH; Batista JL; Olumi AF; Mucci LA; Adami HO; Sørensen HT
    Eur Urol; 2014 Dec; 66(6):1012-20. PubMed ID: 24857538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Metformin and Statin Use on Survival in Pancreatic Cancer Patients: a Systematic Literature Review and Meta-analysis.
    Jian-Yu E ; Graber JM; Lu SE; Lin Y; Lu-Yao G; Tan XL
    Curr Med Chem; 2018; 25(22):2595-2607. PubMed ID: 28403788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Impact of Metformin Use with Survival Outcomes in Urologic Cancers: A Systematic Review and Meta-Analysis.
    Yao X; Liu H; Xu H
    Biomed Res Int; 2021; 2021():5311828. PubMed ID: 34660791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metformin association with lower prostate cancer recurrence in type 2 diabetes: a systematic review and meta-analysis.
    Hwang IC; Park SM; Shin D; Ahn HY; Rieken M; Shariat SF
    Asian Pac J Cancer Prev; 2015; 16(2):595-600. PubMed ID: 25684493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The association between metformin use and colorectal cancer survival among patients with diabetes mellitus: An updated meta-analysis.
    Tian S; Lei HB; Liu YL; Chen Y; Dong WG
    Chronic Dis Transl Med; 2017 Sep; 3(3):169-175. PubMed ID: 29063073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metformin use improves survival of diabetic liver cancer patients: systematic review and meta-analysis.
    Ma SJ; Zheng YX; Zhou PC; Xiao YN; Tan HZ
    Oncotarget; 2016 Oct; 7(40):66202-66211. PubMed ID: 27494848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metformin Use Is Associated With Better Survival of Breast Cancer Patients With Diabetes: A Meta-Analysis.
    Xu H; Chen K; Jia X; Tian Y; Dai Y; Li D; Xie J; Tao M; Mao Y
    Oncologist; 2015 Nov; 20(11):1236-44. PubMed ID: 26446233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of metformin use on survival in kidney cancer patients with diabetes: a meta-analysis.
    Li Y; Hu L; Xia Q; Yuan Y; Mi Y
    Int Urol Nephrol; 2017 Jun; 49(6):975-981. PubMed ID: 28271326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.